New testing approach improves pulmonary fibrosis diagnosis and treatment
· News-Medical"Genetic and telomere testing may help elucidate why disease is occurring, guide management decisions and identify family members who may be at risk," Dr. Carmona says.
Beyond individual patients, the findings have important implications for families. Identifying a genetic cause can help flag relatives who may be at risk, allowing them to pursue earlier screening, genetic counseling and testing.
Mayo Clinic plans to expand this model and launch a Familial Pulmonary Fibrosis Clinic to further coordinate genetic testing, counseling and comprehensive care for patients and at-risk relatives.
Source:
Journal reference: